ConductScience.org, home
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
API referenceFor AI assistants

Trial · NCT01272219

Participant flow66

How many started, completed or left each group, period by period.

1 to 20 of 66

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Main Period: Week 0 to Week 56STARTEDLiraglutide 3.0 mg, no Pre-diabetes959
Main Period: Week 0 to Week 56STARTEDLiraglutide 3.0mg (week0-56)/Liraglutide 3.0mg (week56-68)0
Main Period: Week 0 to Week 56STARTEDLiraglutide 3.0mg (week0-56)/Liraglutide Placebo (week56-68)0
Main Period: Week 0 to Week 56STARTEDLiraglutide Placebo, no Pre-diabetes487
Main Period: Week 0 to Week 56STARTEDLiraglutide 3.0 mg, Pre-diabetes1,528
Main Period: Week 0 to Week 56STARTEDLiraglutide Placebo, Pre-diabetes757
Main Period: Week 0 to Week 56ExposedLiraglutide 3.0 mg, no Pre-diabetes957
Main Period: Week 0 to Week 56ExposedLiraglutide 3.0mg (week0-56)/Liraglutide 3.0mg (week56-68)0
Main Period: Week 0 to Week 56ExposedLiraglutide 3.0mg (week0-56)/Liraglutide Placebo (week56-68)0
Main Period: Week 0 to Week 56ExposedLiraglutide Placebo, no Pre-diabetes487
Main Period: Week 0 to Week 56ExposedLiraglutide 3.0 mg, Pre-diabetes1,524
Main Period: Week 0 to Week 56ExposedLiraglutide Placebo, Pre-diabetes755
Main Period: Week 0 to Week 56COMPLETEDLiraglutide 3.0 mg, no Pre-diabetes679
Main Period: Week 0 to Week 56COMPLETEDLiraglutide 3.0mg (week0-56)/Liraglutide 3.0mg (week56-68)0
Main Period: Week 0 to Week 56COMPLETEDLiraglutide 3.0mg (week0-56)/Liraglutide Placebo (week56-68)0
Main Period: Week 0 to Week 56COMPLETEDLiraglutide Placebo, no Pre-diabetes296
Main Period: Week 0 to Week 56COMPLETEDLiraglutide 3.0 mg, Pre-diabetes1,110
Main Period: Week 0 to Week 56COMPLETEDLiraglutide Placebo, Pre-diabetes505
Main Period: Week 0 to Week 56NOT COMPLETEDLiraglutide 3.0 mg, no Pre-diabetes280
Main Period: Week 0 to Week 56NOT COMPLETEDLiraglutide 3.0mg (week0-56)/Liraglutide 3.0mg (week56-68)0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01272219/flow

API referenceFor AI assistants